Professional Documents
Culture Documents
Introduction To Drug Naming: Angela G. Long, M.S. Senior Vice President, Global Alliances and Organizational Affairs
Introduction To Drug Naming: Angela G. Long, M.S. Senior Vice President, Global Alliances and Organizational Affairs
Introduction To Drug Naming: Angela G. Long, M.S. Senior Vice President, Global Alliances and Organizational Affairs
3
US Adopted Names Council
4
USP-USAN Dictionary Entry
5
USAN Entry for Insulin Human
6
Biologics Naming: INN/USAN
8
USP Naming/Nomenclature in the Law
12
The Nonproprietary Name Provides the Link to
USP’s Publicly Available Quality Standards
USP’s Expert Committees
15
Scientific Considerations for Naming
Recommendations from USP’s
Biologics Expert Committees
Tina S. Morris, Ph.D.
Vice President, Biologics & Biotechnology
Boundary Assumption
17
USP Name and Compendial Identity
Several orthogonal
Identity Tests:
procedures should
1. Chromatographic Purity by HPLC probe different
2. Peptide Mapping identifying attributes
of the article,
Bioidentity: Bioassay
including the primary
sequence.
19
The Challenge of Glycosylation
20
Isoelectric Patterns of Epoetin a and b